Currently, the CFTR gene editing approaches have been explored in cultured primary airway basal cells, iPS cells, and organoid cultures derived from patients with CF. Theoretically, gene editing in airway basal cells in vitro can be used for autologous cell therapy to regenerate airways with CFTR functional cells. This evidence concerns the gene CFTR and cystic fibrosis.